UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Risk-sharing agreements back up economic feasibility review’
by Kim Yun-mi
2019-05-22 14:46
Regulator inspecting Kolon TissuGene in US this week
by Lee Hye-seon
2019-05-20 14:22
Expat students worry about hefty medical insurance fees from mid-July
by Lee Han-soo
2019-05-14 14:17
State-funded smoking cessation program may face overhaul
by Kwak Sung-sun
2019-05-09 15:19
‘Invossa scandal might be more far-reaching’
by Jeong Sae-im
2019-04-26 18:08
라인
Korea succeeds in reducing inflow of foreign tuberculosis patients
by Lee Han-soo
2019-04-26 17:58
Korea to cooperate on healthcare with 3 Central Asian countries
by Lee Han-soo
2019-04-24 17:10
‘Consider N. Korea’s adoption of health insurance in inter-Korean exchange’
by Kwak Sung-sun
2019-04-24 14:28
Regulator suspends Eutilex’ trial on cell therapy
by Jeong Sae-im
2019-04-23 15:13
IVI-led consortium wins Fleming Fund's grant
by Lee Han-soo
2019-04-18 11:15
라인
THAAD backlash almost over: Chinese patients to Korea up 18 %
by Kwak Sung-sun
2019-04-17 16:00
HIRA generates ₩35 billion worth economic value through international biz
by Song Soo-youn
2019-04-16 16:19
Anti-abortion law ruled unconstitutional in Korea
by Choi Gwang-seok
2019-04-11 18:02
Generic drug approvals doubled amid imminent scrap of consigned bioequivalence tests
by Lee Hye-seon
2019-04-11 16:00
Regulator to probe Kolon with all possible scenarios over Invossa debacle
by Lee Hye-seon
2019-04-10 15:37
라인
Korea to spend ₩480 billion for pharma, biotech sector
by Kwak Sung-sun
2019-04-10 15:32
Bill supporting high-tech biopharmaceuticals blocked amid Invossa setback
by Kwak Sung-sun
2019-04-05 16:15
Bodybuilders booked for smuggling anabolic steroids
by Lee Hye-seon
2019-04-05 12:23
Anticipation grows for bill to support advanced biopharmaceuticals
by Lee Hye-seon
2019-04-04 15:25
‘Regulator responsible for suspension of Invossa’
by Song Soo-youn
2019-04-02 15:58
-
이전
21
22
23
24
25
26
27
28
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top